Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Pro-Asp)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004459 AN007465 Untargeted Metabolomics Reveals Tissue-Specific Metabolic Reprogramming and Adaptation Strategies in Astragalus membranaceus var. mongholicus Seedlings under Drought Stress Whole Plant Plant Yili Normal University LC-MS
ST004425 AN007402 Natural triterpenic phenolic esters target PfA-M17 in Plasmodium falciparum Plasmodium cells Parasite Malaria Pennsylvania State University LC-MS
ST004424 AN007401 Stereochemistry-Driven Design and Synthesis of Tadalafil Analogues as Antiplasmodial Agents Plasmodium cells Parasite Malaria Pennsylvania State University LC-MS
ST004333 AN007236 Oxidative pentose phosphate pathway is required for T cell activation and anti-tumor immunity - G6PD-knockout T-cells Mouse Cancer Princeton University LC-MS
ST004301 AN007163 Metabolomic profiling of three native North American ash trees (Fraxinus spp.) and their relationship to the Emerald ash borer (Agrilus planipennis) infestation Plant tissues Green ash, Black ash, White ash Parasitic infestation Cornell University LC-MS
ST004190 AN006961 Comparative Analysis of the Metabolic Profiles of Alix−/− and Ozz−/− Soleus Skeletal Muscle Muscle Mouse St Jude Children's Research Hospital LC-MS
ST004190 AN006962 Comparative Analysis of the Metabolic Profiles of Alix−/− and Ozz−/− Soleus Skeletal Muscle Muscle Mouse St Jude Children's Research Hospital LC-MS
ST004153 AN006895 Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model Feces Rat Shanghai Jiao Tong University LC-MS
ST004138 AN006860 Variation in microbiome and metabolites are associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus Feces Human Autoimmune disease Hangzhou Xixi Hospital LC-MS
ST004138 AN006860 Variation in microbiome and metabolites are associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus Feces Human Liver disease Hangzhou Xixi Hospital LC-MS
ST004017 AN006622 Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance Infected Red Blood Cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST004017 AN006623 Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance Infected Red Blood Cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST003906 AN006411 Neither Plasmodium falciparum Plasmepsin Copy Number Nor Piperaquine Treatment Impact Hemoglobin Digestion Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST003656 AN006006 Profiling the human beta cell's molecular metabolic response to glucose Pancreas Human Diabetes Dana Farber Cancer Institute LC-MS
ST003642 AN005981 Hexosamine Biosynthesis Disruption Impairs GPI Production and Arrests Plasmodium falciparum Growth at Schizont Stages Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST003565 AN005857 Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST003224 AN005286 The Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD0156 is a Potent Inhibitor of Plasmodium Phosphatidylinositol 4-Kinase and is an Attractive Candidate for Repositioning Against Malaria Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST003213 AN005269 The central role of creatine and polyamines in fetal growth restriction Placenta Human Placenta disease University of Udine LC-MS
ST003179 AN005221 Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
ST002998 AN004925 The role of gut microbiota in muscle mitochondria function, colon health, and sarcopenia: from clinical to bench Bacterial cells Faecalibacterium prausnitzii Sarcopenia Chinese University of Hong Kong GC-MS/LC-MS
ST002998 AN004925 The role of gut microbiota in muscle mitochondria function, colon health, and sarcopenia: from clinical to bench Bacterial cells Lacticaseibacillus rhamnosus Sarcopenia Chinese University of Hong Kong GC-MS/LC-MS
ST002977 AN004887 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan LC-MS
ST002977 AN004888 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan LC-MS
ST002977 AN004889 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides fragilis Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides thetaiotaomicron Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides uniformis Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Blautia producta Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium clostridioforme Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hathewayi Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hylemonae Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium scindens Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium symbiosum Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecalis Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecium Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus hirae Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Escherichia fergusonii Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Flavonifractor plautii Stanford University LC-MS
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Parabacteroides distasonis Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides fragilis Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides thetaiotaomicron Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides uniformis Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Blautia producta Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium clostridioforme Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hathewayi Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hylemonae Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium scindens Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium symbiosum Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecalis Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecium Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus hirae Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Escherichia fergusonii Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Flavonifractor plautii Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Parabacteroides distasonis Stanford University LC-MS
ST002747 AN004455 Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections Cultured cells Human CZ Biohub LC-MS
ST002747 AN004455 Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections Cultured cells Rickettsia parkeri CZ Biohub LC-MS
ST002512 AN004137 Gnotobiotic mice: Metabolites in intestinal contents of germ-free mice colonized with strains of gut bacterium Eggerthella lenta Intestine Mouse University of California, San Francisco LC-MS
ST002505 AN004126 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
ST002407 AN003924 Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract Intestine Human University of California, Davis LC-MS
ST002405 AN003919 Stool global metabolite levels in peanut allergy (Part 2) Feces Human Peanut allergy Icahn School of Medicine at Mount Sinai LC-MS
ST002309 AN003771 Targeting malaria parasites with novel derivatives of azithromycin Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002306 AN003768 Metabolomics profiling of full extracts of bacterial culture supernatants. Bacterial cells Bacillus megaterium Myalgic encephalomyelitis/chronic fatigue syndrome University of Connecticut LC-MS
ST002306 AN003768 Metabolomics profiling of full extracts of bacterial culture supernatants. Bacterial cells Enterococcus faecium Myalgic encephalomyelitis/chronic fatigue syndrome University of Connecticut LC-MS
ST002247 AN003670 Microbiota and Health Study (Dhaka, Bangladesh) Feces Human Broad Institute of MIT and Harvard LC-MS
ST002078 AN003387 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST002078 AN003388 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST002078 AN003389 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST002078 AN003390 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST002024 AN003294 Plasmodium falciparum stable-isotope carbon labeling to explore metabolic consequences of keto–acid dehydrogenase disruption Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST002011 AN003277 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST002011 AN003278 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST002011 AN003279 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST002009 AN003275 Metabolomics analysis of stress erythroid progenitors Stem cells Mouse Inflammation Pennsylvania State University LC-MS
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Blood Human Malaria Pennsylvania State University LC-MS
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Blood Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Cultured cells Human Malaria Pennsylvania State University LC-MS
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001794 AN002912 Metabolomics Analysis of Time-Series Gastrointestinal Lumen Samples Jejunum Human University of California, Davis LC-MS
ST001714 AN002789 Metabolomic Profiling of Atovaquone and Atovaquone-like Resistance Lines Parasite Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001714 AN002790 Metabolomic Profiling of Atovaquone and Atovaquone-like Resistance Lines Parasite Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001714 AN002791 Metabolomic Profiling of Atovaquone and Atovaquone-like Resistance Lines Parasite Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001660 AN002711 Plasmodium falciparum metabolomics as a result of treatment with putative acetyl-CoA synthetase inhibitors Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001324 AN002202 Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress Hepatopancreas Pacific Abalone Institute of Oceanology, Chinese Academy of Sciences LC-MS
ST001315 AN002189 Retargeting azithromycin-like compounds as antimalarials with dual modality Blood Plasmodium falciparum Malaria Monash University LC-MS
ST001279 AN002120 K13 mutations driving artemisinin resistance rewrite Plasmodium falciparum’s programmed intra-erythrocytic development and transform mitochondrial physiology Parasite Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001232 AN002050 Combining stage - specificity and metabolomic profiling to advance drug discovery for malaria Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001188 AN001980 P. falciparum infected erythrocytes Cultured cells Plasmodium falciparum Malaria University of Melbourne LC-MS
ST001149 AN001896 Plasmodium Niemann-Pick Type C1-Related Protein is a Druggable Target Required for Parasite Membrane Homeostasis Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001074 AN001756 Open source discovery of starting points for next generation chemoprotective antimalarial drugs (Biofocus 1) Parasite Human Pennsylvania State University LC-MS
ST000441 AN000692 Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways Plasmodium cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST000046 AN000078 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic LC-MS
  logo